Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider ...

Summit Therapeutics (SMMT) stock plunges 35% a day after the FDA approval of partner Akeso's (AKESF) cancer drug, ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

The biotech industry has been under pressure due to the global uncertainty caused by the tariff war. Though pharmaceuticals ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

Enteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and ...

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, according to a new study. Patients should be treated earlier with statins and the ...

The findings suggest that treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.